Format

Send to

Choose Destination
J Neurointerv Surg. 2018 Mar;10(3):315-320. doi: 10.1136/neurintsurg-2017-013554. Epub 2018 Jan 11.

Neuroendovascular management of emergent large vessel occlusion: update on the technical aspects and standards of practice by the Standards and Guidelines Committee of the Society of NeuroInterventional Surgery.

Author information

1
Department of Neurosurgery, Westchester Medical Center at New York Medical College, Valhalla, New York, USA.
2
Department of Neurology, Rutgers University-Robert Wood Johnson University Hospital, New Brunswick, New Jersey, USA.
3
Mount Sinai Cerebrovascular Center, Mount Sinai Hospital, New York, USA.
4
Department of Neurosurgery, University of Cincinnati, Cincinnati, Ohio, USA.
5
Department of Neurological Surgery, University of Cincinnati, Cincinnati, OH, USA.
6
Christiana Care Health Systems, Department of Neurointerventional Surgery, Newark, Delaware, USA.
7
Department of Radiology, Neurology, and Neurological Surgery, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
8
Department of Neurosurgery, Semmes-Murphey Clinic, Memphis, Tennessee, USA.
9
Cerebrovascular Center, Neurological Institute, NeurologicalInstitute, Cleveland Clinic, Cleveland, Ohio, USA.
10
Department of Radiology, Erlanger Medical Center, Chattanooga, Tennessee, USA.
11
Division of Neurosurgery, University of Connecticut, Farmington, Connecticut, USA.
12
Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
13
Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA.
14
Interventional Neuroradiology and Neuroendovascular Surgery, Miami Cardiac and Vascular Institute and Baptist Neuroscience Center, Miami, Florida, USA.
15
Interventional Neuroradiology, Radiology Imaging Associates, Englewood, Colorado, USA.
16
Interventional Neuroradiology, The University of California San Francisco, San Francisco, California, USA.
17
Radiology, Warren Alpert School of Medical at Brown University, Providence, Rhode Island, USA.
18
Neurointerventional Radiology, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA.
19
Houston Methodist Hospital, Houston, Texas, USA.
20
Department of Radiology, The University of Chicago, Chicago, Illinois, USA.
21
Department of Neurosurgery, University of Southern California, Los Angeles, California, USA.
22
Department of Neurosurgery, Massachusetts General Hospital, Boston, Massachusetts, USA.
23
Radiology and Neurological Surgery, Columbia University, College of Physicians and Surgeons, Neurological Institute of New York, New York, USA.
24
Department of Neurosurgery, University of South Florida, Tampa, Florida, USA.
25
Department of Neurological surgery, New York Presbyterian Hospital/ Weill Cornell Medicine, New York, UK.
26
Departments of Radiology and Neurosurgery, The University of Texas Southwestern Medical Center, Dallas, Texas, USA.
27
Departments of Neurosurgery and Radiology, University of Miami, Miami, Florida, USA.
28
Department of Radiology, Banner University Medical Center, Phoenix, Arizona, USA.
29
Departments of Neurological Surgery, Neurology, Radiology and Neuroscience, University of Kentucky, Lexington, Kentucky, USA.

KEYWORDS:

standards; stroke; technique; thrombectomy

Conflict of interest statement

Competing interests: Dr Chen reports being a consultant for Medtronic, Penumbra, Stryker and Genentech Dr Fraser is an equity interest holder for Fawkes Biotechnology, LLC, and a consultant for Stream Biomedical. Dr Hetts reports being a consultant for Medina and Neuravi, as well as research contracts with Stryker Neurovascular, Siemens, Micro Vention Terumo. Dr. Klucznik reports being a proctor and speaker for Medtronic. Dr Mocco reports the following: Consultant: Rebound Therapeutics, TSP Inc., Cerebrotech, Lazarus Effect, Pulsar, Medina. investor: Blockade Medical, TSP Inc., Lazarus effect, Medina PI/CO-PI for the following trials: THERAPY (PI), FEAT (PI), INVEST (Co-PI), COMPASS (Co-PI), LARGE (Co-PI), COAST (Co-PI), POSITIVE (Co-PI). Steering committee for the MAPS trial. Dr Prestigiacomo reports the following: Consultant, Codman Neurovascular (serving on DSMB) Dr Pride reports the following: Consultant, Sequent Medical (DSMB for Web-IT study) Dr Sunenshine reports protctoring for Medtronic, and is an investigator in STRATIS (Medtronic) and CARE (Penumbra) studies. All other authors report no relevant conflicts of interest.

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center